These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 31806394

  • 1. Relationship of Plasminogen Activator Inhibitor 1 4G/5G Gene Polymorphism and Nontraumatic Lunatum Avascular Necrosis.
    Gönen M, Yörükoğlu AÇ, Aydemir AN, Gönen GA, Tepeli E, Demirkan AF.
    J Hand Surg Am; 2020 May; 45(5):450.e1-450.e4. PubMed ID: 31806394
    [Abstract] [Full Text] [Related]

  • 2. Relationship between post-SARS osteonecrosis and PAI-1 4G/5G gene polymorphisms.
    Sun W, Li Z, Shi Z, Wang B, Gao F, Yang Y, Guo W.
    Eur J Orthop Surg Traumatol; 2014 May; 24(4):525-9. PubMed ID: 23589033
    [Abstract] [Full Text] [Related]

  • 3. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT, Wiman B, Vettore S, Dazzi F, Girolami A, Patrassi GM.
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [Abstract] [Full Text] [Related]

  • 4. The Association of Plasminogen Activator Inhibitor Type 1 (PAI-1) Level and PAI-1 4G/5G Gene Polymorphism with the Formation and the Grade of Endometrial Cancer.
    Yıldırım ME, Karakuş S, Kurtulgan HK, Kılıçgün H, Erşan S, Bakır S.
    Biochem Genet; 2017 Aug; 55(4):314-321. PubMed ID: 28303356
    [Abstract] [Full Text] [Related]

  • 5. Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis.
    Gürkan A, Emingil G, Saygan BH, Cinarcik S, Atilla G, Köse T, Berdeli A.
    J Periodontol; 2007 Jul; 78(7):1256-63. PubMed ID: 17608581
    [Abstract] [Full Text] [Related]

  • 6. Plasminogen activator inhibitor-1 gene polymorphism 4G/4G genotype and lupus nephritis in Chinese patients.
    Wang AY, Poon P, Lai FM, Yu L, Choi PC, Lui SF, Li PK.
    Kidney Int; 2001 Apr; 59(4):1520-8. PubMed ID: 11260416
    [Abstract] [Full Text] [Related]

  • 7. A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes.
    Yenilmez C, Ozdemir Koroglu Z, Kurt H, Yanas M, Colak E, Degirmenci I, Gunes HV.
    J Clin Pharm Ther; 2017 Feb; 42(1):103-107. PubMed ID: 27796029
    [Abstract] [Full Text] [Related]

  • 8. Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients.
    Ferrari P, Schroeder V, Anderson S, Kocovic L, Vogt B, Schiesser D, Marti HP, Ganz R, Frey FJ, Kohler HP.
    Transplantation; 2002 Oct 27; 74(8):1147-52. PubMed ID: 12438962
    [Abstract] [Full Text] [Related]

  • 9. Plasminogen activator inhibitor I 4G/5G polymorphism in neonatal respiratory distress syndrome.
    Armangil D, Yurdakök M, Okur H, Gürgey A.
    Clin Appl Thromb Hemost; 2011 Aug 27; 17(4):352-7. PubMed ID: 20460339
    [Abstract] [Full Text] [Related]

  • 10. Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in Turkish children with asthma and allergic rhinitis.
    Ozbek OY, Ataç FB, Ogus E, Ozbek N.
    Allergy Asthma Proc; 2009 Aug 27; 30(1):41-6. PubMed ID: 19063817
    [Abstract] [Full Text] [Related]

  • 11. Plasminogen activator inhibitor-1 and susceptibility to lung cancer: a population genetics perspective.
    Bayramoglu A, Gunes HV, Metintas M, Degirmenci I, Guler HI, Ustuner C, Musmul A.
    Genet Test Mol Biomarkers; 2014 Aug 27; 18(8):587-90. PubMed ID: 24955483
    [Abstract] [Full Text] [Related]

  • 12. Plasminogen activator inhibitor -1 gene 4G/5G polymorphism in patients with breast cancer.
    Eroglu A, Ulu A, Cam R, Akar N.
    J BUON; 2006 Aug 27; 11(4):481-4. PubMed ID: 17309181
    [Abstract] [Full Text] [Related]

  • 13. The -675 4G/5G polymorphism at the Plasminogen Activator Inhibitor 1 (PAI-1) gene modulates plasma Plasminogen Activator Inhibitor 1 concentrations in response to dietary fat consumption.
    Pérez-Martínez P, Adarraga-Cansino MD, Fernández de la Puebla RA, Blanco-Molina A, Delgado-Lista J, Marín C, Ordovás JM, López-Miranda J, Pérez-Jiménez F.
    Br J Nutr; 2008 Apr 27; 99(4):699-702. PubMed ID: 17903340
    [Abstract] [Full Text] [Related]

  • 14. Association of plasminogen activator inhibitor-1 gene polymorphism and type 2 diabetic nephropathy.
    Xu F, Liu H, Sun Y.
    Ren Fail; 2016 Apr 27; 38(1):157-62. PubMed ID: 26616527
    [Abstract] [Full Text] [Related]

  • 15. Plasminogen activator inhibitor-1 5G/5G genotype is associated with early spontaneous recanalization of the infarct-related artery in patients presenting with acute ST-elevation myocardial infarction.
    Cagliyan CE, Yuregir OO, Balli M, Tekin K, Akilli RE, Bozdogan ST, Turkmen S, Deniz A, Baykan OA, Aslan H, Cayli M.
    Coron Artery Dis; 2013 May 27; 24(3):196-200. PubMed ID: 23283030
    [Abstract] [Full Text] [Related]

  • 16. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.
    Emingil G, Berdeli A, Gürkan A, Han Saygan B, Köse T, Atilla G.
    J Clin Periodontol; 2007 Apr 27; 34(4):278-84. PubMed ID: 17257155
    [Abstract] [Full Text] [Related]

  • 17. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
    Jorgenson E, Deitcher SR, Cicek M, Liu X, Plummer S, Casey G, Witte JS.
    Prostate; 2007 Feb 01; 67(2):172-7. PubMed ID: 17044080
    [Abstract] [Full Text] [Related]

  • 18. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
    Jastrzebska M, Widecka K, Ciechanowicz A, Goracy I, Wesołowska T, Torbus-Lisiecka B, Foltyńska-Nowakowska A, Naruszewicz M.
    Pol Arch Med Wewn; 2005 Jan 01; 113(1):7-20. PubMed ID: 16130596
    [Abstract] [Full Text] [Related]

  • 19. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.
    Castelló R, España F, Vázquez C, Fuster C, Almenar SM, Aznar J, Estellés A.
    Thromb Res; 2006 Jan 01; 117(5):487-92. PubMed ID: 15907980
    [Abstract] [Full Text] [Related]

  • 20. [Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome].
    Reshetniak TM, Ostriakova EV, Patrusheva NL, Patrushev LI, Aleksandrova EN, Seredavkina NV, Volkov AV, Nasonov EL.
    Ter Arkh; 2013 Jan 01; 85(1):76-84. PubMed ID: 23536951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.